Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi/Zealand Release Head-To-Head Data For Lixisenatide Vs. Exenatide

Feb 02 2011

• By The Pink Sheet Daily

Related Content

Victoza Outperforms Byetta In Head-To-Head Trial

Jun 08 2009

Can Bydureon Bounce Back? Amylin's Proposed Cardio Safety Trial Is A Faster Option

Jan 10 2011

Novo Nordisk's GLP-1 Victoza Off To A Good Start

Apr 27 2010

FDA Clears Victoza, But Warnings And More Studies Pose Hurdles

Feb 01 2010

Roche/Ipsen's Suspended Taspoglutide Could Become Another Diabetes Casualty

Sep 10 2010

Sanofi's Lixisenatide/Lantus Combo Could Be A Critical Growth Driver

Sep 30 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window